Walker Neal 4

4 · Aclaris Therapeutics, Inc. · Filed Feb 5, 2026

AI-generated summary of this filing

Updated Feb 5, 2026

Aclaris (ACRS) CEO Neal Walker Receives Award, 63,475 Shares

What Happened

Neal Walker, CEO and Director of Aclaris Therapeutics (ACRS), had 63,475 restricted stock units (RSUs) settle on February 3, 2026.
Of those, 18,611 shares were withheld to cover tax withholding at $3.47 per share, totaling $64,580, leaving a net of 44,864 shares added to his holdings.
This was an award settlement (vesting/conversion of RSUs), not an open-market purchase or voluntary sale; the only disposition was the issuer withholding shares for taxes.

Key Details

Transaction date: 2026-02-03; Form 4 filed: 2026-02-05 (filed timely).
Gross shares issued on settlement: 63,475 RSUs → 63,475 shares.
Shares withheld for tax payment: 18,611 shares @ $3.47 = $64,580 (disposed under withholding code F).
Net shares received: 44,864.
Shares owned after transaction: not specified in the provided excerpt of the Form 4.
Footnotes: F1 clarifies each RSU converts to one common share; F2 confirms share withholding satisfied tax obligations; F3 notes these RSUs vest in four equal annual installments starting Feb 3, 2025, subject to continuous service.

Context

This is a routine RSU vesting/settlement event. The withholding of shares to cover taxes is common and does not necessarily indicate a trading view by the insider.
The filing shows conversion/exercise treatment for the RSUs on the Form 4; no open-market purchases or voluntary sales (other than the tax-withholding disposition) were reported.

Form 4

Period: 2026-02-03

DirectorCEO

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-03+63,475→ 1,562,497 total
Tax Payment
Common Stock
[F2]
2026-02-03$3.47/sh−18,611$64,580→ 1,543,886 total
Exercise/Conversion
Restricted Stock Units
[F1][F3]
2026-02-03−63,475→ 190,425 total
→ Common Stock (63,475 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
[F2]The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4.
[F3]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 3, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Signature

/s/ Matthew Rothman, Attorney-in-Fact|2026-02-05

1 file